Chapters 11–13,Appendices A–C,References

Administration of Radioactive Substances Advisory Committee (2000) UK notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. Nucl. Med. Commun. 21 (Suppl.), S1–S91.

Aerts M.G. (2000) Cremation of Corpses Containing Bone-seeking Radionuclides Following Medical Treatment. In: Proceedings of the IRPA 10 Meeting, International Society of Radiation Protection, Hiroshima, 14–19 May.

Australian Radiation Protection and Nuclear Safety Agency (2002) Discharge of Patients Undergoing Treatment with Radioactive Substances. Radiation Protection Series No. 4. ARPANSA. http://www.arpansa.gov.au/rps-pubs.htm.

Barrington S.F. Kettle A.G. O'Doherty M.J. (1996a) Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid. Eur. J. Nucl. Med. 23, 123–130.

Barrington S.F. Kettle A.G. Thompson W.H. (1996b) RCP guidelines on radiation protection following radioiodine therapy for hyperthyroidism: are they appropriate?. Nucl. Med. Commun. 17, 275.

Barrington S.F. O'Doherty M.J. Kettle A.G. (1999) Radiation exposure of families of outpatients treated with radioactive iodine (iodine-131) for hyperthyroidism. Eur. J. Nucl. Med. 26, 686–692.

Barrington S.F. Anderson P. Kettle A.G. (2003) Does significant contamination occur in families of patients treated with 131-I for hyperthyroidism?. Eur. J. Nucl. Med. 30 (Suppl. 2), S164 (Abstract 69).

Beierwaltes W.H. Widman J. (1992) How harmful to others are iodine-131 treated patients: an editorial. J. Nucl. Med. 33, 2116–2117.

British Institute of Radiology (1999). Patients leaving hospital after administration of radioactive substances. Br. J. Radiol. 72, 121–125.

Buchan R.C.T. Brindle M.A. (1971) Radioiodine therapy to out-patients — the radiation hazard. Br. J. Radiol. 44, 973–975.

Buchan R.C.T. Brindle M.A. (1970) Radioiodine therapy to out-patients — the contamination hazard. Br. J. Radiol. 43, 479–483.

Buettner C. Surks M. (2003) Police detainment of a patient following treatment with radioactive iodine. JAMA 288, 2687–2688.

Castronovo F.P. Beh R.A. Veilleux N.M. (1986) Iodine-131 therapy patients: radiation dose to staff. Radiat. Prot. Dosim. 15, 45–49.

Chavin W. Cukrowski C.A. (1968) Effects of iodine-131 on the thyroid and pituitary of goldfish (carassius auratus). Radiat. Res. 34, 170–199.

Copplestone D. Toal M.E.D. Johnson M.S. (2000) Environmental effects of radionuclides — observations on natural ecosystems. J. Radiat. Prot. 20, 29–40.

Coover L.R. Silberstein E.B. Kuhn P.J. (2000) Therapeutic ¹³¹iodine in outpatients: a simplified method of conforming to the Code of Federal Regulations, Title 10 Part 35.75. J. Nucl. Med. 41, 1868–1875.

Crockett G. (2000) Sources and fate of discharges of liquid radioactive waste to public sewers. Radiol. Prot. Bull. 226, 19–24.

Culver C.M. Dworkin H.J. (1991) Radiation safety considerations for post-iodine-131 hyperthyroid therapy. J. Nucl. Med. 32, 169–173.

deKlerk J.M.H. (2000) Iodine-131 therapy: inpatient or outpatient?. J. Nucl. Med. 41, 1876–1878.

Denman A.R. Martin S. (2001) Care of a terminally ill patient following a thyroid ablation dose of ¹³¹I sodium iodide. Br. J. Radiol. 74, 1077–1078.

Dickman P. Holm L. Lundell G. Boice J. Hall P. (2003) Thyroid cancer risk after thyroid examination with 1311: a population-based cohort study in Sweden. Int. J. Cancer 106, 580–587.

Driver I. Packer S. (2001) Radioactive waste discharge quantities for patients undergoing radioactive iodine therapy for thyroid carcinoma. Nucl. Med. Commun. 22, 1129–1132.

Eisenbud M. (1973) Environmental Radioactivity, 2nd edn. Academic Press, New York.

Erlandsson B. Mattsson S. (1978) Medically used radionuclides in sewage sludge. Water Air Soil Pollut. 9, 199–206.

Environment Agency (2000) UK Investigation of the Sources and Fate of Radioactive Discharges into Public Sewers. R&D Technical Report P288. Environment Agency, London.

European Commission (1998) Radiation Protection 97, Radiation Protection Following Iodine-131 (Exposures due to Outpatients or Discharged Inpatients). European Commission, Luxembourg.

European Thyroid Association (1996) ¹³¹ I Therapy for hyperthyroidism towards 2000. Eur. J. Nucl. Med. 23, BP13–BP15.

European Union (1996) Council of the European Union: Guideline 96/29 EURATOM to determine basic directions of health protection of public and workers against ionizing radiation related dangers. Official J. Eur. Community No. L, 159/1.

European Union (1997) Council of the European Union: Council directive 1997/43/EURATOM on health protection of individuals against ionizing radiation in relation to medical exposure. Official J. Eur. Community No. L, 180.

EURATOM (1997) Expert Group ex. art 31 Guidance of Radiation Protection Following Iodine Therapy Concerning Doses due to Outpatients or Discharged Inpatients. EURATOM, Brussels.

Evdokimoff V. Cash C. Buckley K. Cardenas A. (1994) Potential for radioactive patient excreta in hospital trash and medical waste. Health Phys. 66, 209–211.

Fenner F.D. Martin J.E. (1997) Behavior of Na ¹³¹ I and meta ( ¹³¹ I) iodobenzylguanidine (MIBG) in municipal sewerage. Health Phys. 73, 333–339.

Griffiths P.A. Jones G.P. Marshall C. Powley S.C. (2000) Radiation protection consequences of the care of a terminally ill patient having received a thyroid ablation dose of ¹³¹ sodium iodide. Br. J. Radiol. 73, 1209–1212.

Gunesekera R. Thompson W.H. Harding L.K. (1996) Use of public transport by ¹³¹ I therapy outpatients. Nucl. Med. Commun. 17, 275.

Hanscheid H. Lassmann M. Reiners C.H.R. Aulbach F. (2003) Monitoring of ¹³¹ I incorporation in nuclear medicine personnel by self accomplished measurements. Nuklearmedizin 42, 45–49.

Harris P.J. (1959) A study of thyroid function in Fundulus heteroclitus (killifish). Biol. Bull. 117, 91–98.

Hilditch T.E. Connell J.M.C. Davies D.L. (1991) Radiological protection guidance for radioactive patients — new data for therapeutic ¹³¹ I. Nucl. Med. Commun. 12, 485–495.

Ho S.Y. Shearer D.R. (1992) Radioactive contamination in hospitals from nuclear medicine patients. Health Phys. 62.

Homer L. Smith A.H. (2002) Radiation protection issues of treating hyperthyroidism with ¹³¹ I in patients on haemodialysis. Nucl. Med. Commun. 23, 261–264.

Ibis E. Wilson C.R. Collier B.D. (1992) Iodine-131 contamination from thyroid cancer patients. J. Nucl. Med. 33, 2110–2115.

Ilyin L. Arkhangel'skaya G.V. Konstantinov O. Likhtarev I.A. (1972) Radioactive Iodine in the Problem of Radiation Safety. Atomizdat, Moscow.

International Atomic Energy Agency (1996) Basic Safety Standards. IAEA, Vienna.

International Atomic Energy Agency (2002a) Radiological Protection for Medical Exposure to Ionizing Radiation, Safety Guide No. RS-G-1.5. IAEA, Vienna.

International Atomic Energy Agency (2002b) Detection of Radioactive Materials at Borders, IAEA-TECDOC-1312. IAEA, Vienna.

International Commission on Radiological Protection (1987) Radiation dose to patients from radio pharmaceuticals. ICRP Publication 53, AM-ICRP 18(1–4).

International Commission on Radiological Protection (1991) 1990 Recommendations of the International Commision of Radiological Protection. ICRP Publication 60, Ann. ICRP 21 (1–3).

International Commission on Radiological Protection (1996) Radiological protection and safety in medicine. ICRP Publication 73, Ann. ICRP 26 (2).

International Commission on Radiological Protection (1997) Radiological protection policy for the disposal of radioactive waste. ICRP Publication 77, Ann. ICRP 27 (Suppl.).

International Commission on Radiological Protection (1999) ICRP Database of Dose Coefficients. Workers and Members of the Public, CD-ROM Distributed by Elsevier Ltd, Oxford.

International Commission on Radiological Protection (2000) Pregnancy and medical radiation. ICRP Publication 84, Ann ICRP 30 (1).

International Commission on Radiological Protection (2002) Doses to the embryo and fetus from intakes of radionuclides by the mother. ICRP Publication 88, Ann. ICRP 31 (1–3).

International Commission on Radiological Protection (2003) A framework for assessing the impact of ionising radiation on non-human species. ICRP Publication 91, Ann. ICRP 33(3).

Jacobson A.P. Plato P.A. Toeroek D. (1978) Contamination of the home environment by patients treated with iodine-131: initial results. Am. J. Public Health 68, 225–230.

Johnson T.K. Lin E. Haugen B. (2002) Contamination as a route for ¹³¹ I uptake in family members: implications for public health. J. Nucl. Med. 43 (Suppl.), abstract.

Johnston A.S. Minarcik J. Rossi R. (1979) Autopsy experience with a radioactive cadaver. Health Phys. 37, 231–236.

Kelly J. Finch H. (2002) Benchmarking Public Opinion on the Management of Radioactive Waste. A Report for the Radioactive Substances Division of the Department for the Environment, Food and Rural Affairs.

Kerber R. Till J. Simon S. (1993) A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. JAMA 270, 2076.

Larsen P.R. Conard R. (1978) Thyroid hypofunction appearing as a delayed manifestation of accidental exposure to radioactive fallout in a Marshallese population. Brookhaven National Laboratory Report BNL-24104.

LaRoche G. LeBlond C.P. (1954) Destruction of the thyroid gland of Atlantic salmon by means of radioiodine. Proc. Soc. Exp. Biol. Med. 87, 273–276.

LaRoche G. Johnson C.L. Woodall A.N. (1965) Thyroid function in the rainbow trout: biological and histological evidence of radiothyroidectomy. Gen. Comp. Endocrinol. 5, 145–159.

Lassmann M. Hanscheid H. Schelper L.F. (1998) Measurement of incorporation in family members of patients with benign thyroid disease after radioiodine therapy. Nuklearmedizin 37, 120–123.

Leslie W.D. Havelock J. Palser R. Abrams D.N. (2002) Large-body radiation doses following radioiodine therapy. Nucl. Med. Commun. 23, 1091–1097.

Leung P.M. Nikolic M. (1998) Disposal of therapeutic iodine-131 waste using a multiple holding tank system. Health Phys. 75, 315–321.

Lubin E. (2002) Definitive improvement in the approach to the treated patient as a radioactive source. J. Nucl. Med. 43, 364–365.

Martin J.E. Fenner F.D. (1997) Radioactivity in municipal sewerage and sludge. Public Health Rep., 308–316.

Marcus C.S. Aldrich R. (1997) Avoiding solid waste contamination problems from iodine-131 patients. J. Nucl. Med. 38, 26N.

Mathieu I. Caussin J. Smeesters P. Wamberseie A. Beckers C. (1997) Doses in family members after ¹³¹I treatment. Lancet 350, 1074–1075.

Mathieu I. Caussin J. Smeesters P. (1999) Recommended restrictions after iodine-131 therapy: measured doses in family members. Health Phys. 76, 129–136.

Meek R.A. (1996) Complete decay of radionuclides: implications for low-level waste disposal in municipal landfills. Health Phys. 70, 706–7111.

Monsieurs M. Thierens H. Dierckx R.A. (1998) Real-life radiation burden to relatives of patients treated with iodine-131: a study in 8 centers in Flanders (Belgium). Eur. J. Nucl. Med. 25, 1368–1376.

Moreno Garcia L. (2001) Expectations of Patients' Advocates, Radiological Protection of Patients in Diagnostic and Interventional Radiology, Nuclear Medicine and Radiotherapy. In: Proceedings of an International Conference, Malaga, 26–30 March 2001. International Atomic Energy Agency, Vienna.

National Council on Radiation Protection and Measurements (1970) Precautions in the Management of Patients who have Received Therapeutic Amounts of Radionuclides. Report 37. NCRP, Bethesda.

National Council on Radiation Protection and Measurements (1995) Dose Limits for Individuals who Receive Exposure from Radionuclide Therapy Patients. NCRP Commentary No. 11. NCRP, Bethesda.

National Health and Medical Research Council (1987) Australian Code of Practice for the Safe Handling of Corpses Containing Radioactive Materials (1986). Australian Government Publishing Service, Canberra.

National Radiation Protection Board (1988) Guidance Notes for the Protection of Persons Against Ionising Radiations Arising from Medical and Dental Use. NRPB, Oxon.

National Radiation Protection Board (2000) Institute of Physics and Engineering in Medicine, National Radiological Protection Board, Health and Safety Executive, The Health Departments 2000 Medical and Dental Guidance Notes — a Good Practice Guide to Implement Ionising Radiation Protection Legislation in the Clinical Environment.

Norris D.O. Gorbman A. (1965) Radiothyroidectomy of larval steelhead trout. Proc. Soc. Exp. Biol. Med. 119, 1205–1207.

Nishizawa K. Ohara K. Ohshima M. (1980) Monitoring of I excretions and used materials of patients treated with ¹³¹ I. Health Phys. 38, 467–481.

Nuclear Energy Agency (1995) The Environmental and Ethical Basis of Geological Disposal of Long-lived Radioactive Wastes. A Collective Opinion of the Radioactive Waste Management Committee of the OECD Nuclear Energy Agency. NEA, Paris.

O'Doherty M.J. Kettle A.G. Eustance C.N.P. (1993) Radiation dose rates from adult patients receiving ¹³¹ I therapy for hyperthyroidism. Nucl. Med. Commun. 14, 160–168.

Olivereau M. LaRoche G. (1965) Effects of low iodine intake or destructive doses of iodine-131 on pituitary histochemistry of young Chinook salmon. Am. Zool. 5, 234.

Olivereau M. (1957) Radiothyroidectomie chez l'Anguille. Arch. Anat. Microscop. Morphol. Exptl. 46, 39–59.

Osborn S. Greaves C. Tindale W. (2002) Care of a helpless patient and handling of the radioactive corpse. J. Radiol. Protect. 22, 185–187.

Parthasarathy K.L. (1982) Necropsy of a cadaver containing 50 mCi of sodium 131 iodide. J. Nucl. Med. 23, 777–780.

Pentreath R.J. (2002) Radiation protection of people and the environment: developing a common approach. J. Radiol. Protect. 22, 45–46.

Prichard H.M. Gesell T.F. Davis E. (1981) Iodine-131 levels in sludge and treated municipal wastewaters near a large medical complex. Am. J. Public Health 71, 47–52.

Rallison M.L. Dobyns B.M. Keating F.R. (1974) Thyroid disease in children: a survey of subjects potentially exposed to fallout radiation. Am. J. Med. 56, 457–463.

Reiners C. Lassmann M. (1999) Radioiodine ( ¹³¹ I) treatment of hyperthyroidism: radiation protection and quality assurance. Eur. J. Nucl. Med. 26, 683–685.

Ron E. Lubin J.H. Shore R.E. (1995) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat. Res. 141, 259–277.

Rutar F.J. Augustine S.C. Colcher D. (2001) Outpatient treatment with iodine-131 anti-B1 antibody: radiation exposure to family members. J. Nucl. Med. 42, 90–915.

Saenger E.L. Kereiakes J.G. (1980) Reflections on cancer treatment and the federal agency regulations. Radiology 137, 865–866.

Schomaecker K. Fischer T. Gaidouk M. (2000) Exhalation of iodine-131 after radioiodine therapy: time dependence and chemical form. J. Nucl. Med. 41 (Suppl.), 251P.

Shishkanov N.G. Bakun Y.M. Roziev R.A. (2001) Radiation protection of members of the public contacting patients after therapeutic treatment with radioiodine. Med. Radiol. Radiat. Protect. 5, 34–46 (in Russian).

Siegel J.A. (1999) Outpatient Radionuclide Therapy. In: Proceedings of the Thirty-Fifth Annual Meeting of the National Council on Radiation Protection and Measurements, Proceedings No. 21, 7–8 April 1999, Arlington VA. NCRP, Bethesda.

Siegel J.A. Marcus C.S. Sparks R.B. (2002a) Calculating the absorbed dose from radioactive patients: the line-source versus point-source model. J. Nucl. Med. 43, 1241–1244.

Siegel J.A. Kroll S. Regan D. (2002b) A practical methodology for patient release after tositumomab and iodine-131 tositumomab therapy. J. Nucl. Med. 43, 354–363.

Siegel J.A. Sparks R.B. (2002) Radioactivity appearing at landfills in household trash of nuclear medicine patients: much ado about nothing? Health Phys. 82, 367–372.

Silberstein E.B. Taylor A.T. Jr. (1996) Society of Nuclear Medicine Guideline for Bone Pain Treatment. J. Nucl. Med. 37, 881–884.

Silberstein E.B. Buscombe J.R. Taylor A.T. Jr. (2003) Society of Nuclear Medicine Procedure Guideline for Palliative Treatment of Painful Bone Metastases. Version 3.0. Available at www.snm.org.

Sodd V.J. Velten R.J. Saenger E.L. (1975) Concentrations of the medically useful radionuclides, technetium-99m and iodine-131 at a large metropolitan waste water treatment plant. Health Phys. 28, 355–359.

Swedish Radiation Protection Institute (2000) Regulations and General Advice on Nuclear Medicine. SSI FS 2000–3.

Thompson W. Williams N.R. Harding L.K. (1994) A model of excreted activities of radiopharmaceuticals from patients to the drains. Eur. J. Nucl. Med. 21, 876.

UK Department of the Environment (2002) UK Strategy for Radioactive Discharges 2001–2020. Department for Environment, Food and Rural Affairs, London.

United Nations Scientific Committee on the Effects of Atomic Radiation (2000) Sources and Effects of Ionizing Radiation. 2000 Report to the General Assembly with Annexes, United Nations, Vienna.

US Nuclear Regulatory Commission (1997a) Regulatory Analysis on Criteria for the Release of Patients Administered Radioactive Material, NUREG-1492. USNRC, Washington.

US Nuclear Regulatory Commission (1997b) Release of Patients Administered Radioactive Materials. Regulatory Guide 8.39. USNRC, Washington.

Wellner U. Eschner W. Hillger W. (1998) The exposure of relatives to patients of a nuclear medicine ward after radioiodine therapy by inhalation of ¹³¹ I in their home. Nuklearmedizin 37, 113–119.